Key result
A TAVI patient initially implanted with a DDD pacemaker substantially profited from a later upgrade to cardiac resynchronization therapy.
Why the study?
Does upgrading to cardiac resynchronization therapy improve outcomes in a post-TAVI patient with conduction defects initially treated with a DDD pacemaker?
Case Report (n=1)
Does upgrading to cardiac resynchronization therapy improve outcomes in a post-TAVI patient with conduction defects initially treated with a DDD pacemaker?
Upgrading to CRT may be beneficial for post-TAVI patients who develop conduction defects and are initially treated with a DDD pacemaker.
CRT upgrade benefited one post-TAVI patient with conduction defects; hypothesis-generating and should not yet change practice.
The conduction defects in patients following transcatheter aortic valve implantation (TAVI) are common and difficult to predict. Whether a pacemaker (and which type) should be implanted in this particular group of patients remains a question. We report on the case of a TAVI patient initially implanted with a DDD pacemaker, who substantially profited from a later upgrade to a cardiac resynchronization therapy.
No takes yet. Share an insight, caveat, or question.
Osmančík et al. (2010) conducted a case report in Conduction defects following transcatheter aortic valve implantation (TAVI) (n=1). Cardiac resynchronization therapy vs. DDD pacemaker was evaluated on Clinical improvement. A TAVI patient initially implanted with a DDD pacemaker substantially profited from a later upgrade to cardiac resynchronization therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: